The firm began a Phase II study of evorpacept in HER2-positive breast cancer patients and began testing a higher dose of ALX2004 in a separate Phase I trial.
Publisher NetEase Games and developer Joker Studio will host the “Wanderer” alpha test for free-to-play oceanic adventure RPG Sea of Remnants from February 5 to 12, the companies ...
ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
VANCOUVER, BC, Dec. 31, 2025 /CNW/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035([1]) , driven by a fundamental shift in cancer ...
Chronic kidney disease can quietly reshape a life long before the first lab test comes back abnormal. More than 700 million ...
Researchers created a new kind of cancer drug that can grab a mutant protein while also carrying a second hit against the ...
Panelists discuss how molecular testing and biomarker profiling guide individualized first-line treatment planning for EGFR-mutant non–small cell lung cancer (NSCLC) with central nervous system (CNS) ...
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Mammalian cells express three conjugatable ...
This is a well-written study that presents a solid genetic screen to identify regulators of adipose morphology and remodeling in zebrafish. The authors generated a rigorous screening platform based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback